{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:24:02Z","timestamp":1791480242946,"version":"4.3.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T00:00:00Z","timestamp":1427328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00415-015-7707-6","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T06:26:29Z","timestamp":1427264789000},"page":"1285-1288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Dalfampridine in hereditary spastic paraplegia: a prospective, open study"],"prefix":"10.1007","volume":"262","author":[{"given":"Matthieu","family":"B\u00e9reau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Anheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Tio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andoni","family":"Echaniz-Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Depienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Collongues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"de S\u00e8ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,26]]},"reference":[{"key":"7707_CR1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pharmthera.2005.10.006","volume":"111","author":"SI Judge","year":"2006","unstructured":"Judge SI, Bever CT Jr (2006) Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther 111:224\u2013259","journal-title":"Pharmacol Ther"},{"key":"7707_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0361-9230(89)90126-3","volume":"22","author":"AR Blight","year":"1989","unstructured":"Blight AR (1989) Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res Bull 22:47\u201352","journal-title":"Brain Res Bull"},{"key":"7707_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.1993.10.1","volume":"110","author":"RR Hansebout","year":"1993","unstructured":"Hansebout RR, Blight AR, Fawcett S, Reddy K (1993) 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. J Neurotrauma 110:1\u201318","journal-title":"J Neurotrauma"},{"key":"7707_CR4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sc.1993.40","volume":"31","author":"KC Hayes","year":"1993","unstructured":"Hayes KC, Blight AR, Potter PJ, Allatt RD, Hsieh JT, Wolfe DL, Lam S, Hamilton JT (1993) Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury. Paraplegia 31:216\u2013224","journal-title":"Paraplegia"},{"key":"7707_CR5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/neu.1998.15.837","volume":"15","author":"PJ Potter","year":"1998","unstructured":"Potter PJ, Hayes KC, Segal JL, Hsieh JT, Brunnemann SR, Delaney GA, Tiernay DS, Mason D (1998) Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury. J Neurotrauma 15:837\u2013849","journal-title":"J Neurotrauma"},{"key":"7707_CR6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.22240","volume":"68","author":"AD Goodman","year":"2010","unstructured":"Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR, MSF204 Investigators (2010) A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Ann Neurol 68:494\u2013502","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"7707_CR7","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/0303-8467(92)90010-Z","volume":"94","author":"RP Bruyn","year":"1992","unstructured":"Bruyn RP (1992) The neuropathology of hereditary spastic paraparesis. Clin Neurol Neurosurg 94(Suppl):S16\u2013S18","journal-title":"Clin Neurol Neurosurg"},{"key":"7707_CR8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","volume":"373","author":"AD Goodman","year":"2009","unstructured":"Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR, Fampridine MS-F203 (2009) Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 373:732\u2013738","journal-title":"Lancet"},{"key":"7707_CR9","volume-title":"Multiple sclerosis functional composite (MSFC): administration and scoring manual","author":"JS Fischer","year":"2001","unstructured":"Fischer JS, Jak AJ, Kniler JE, Cutter G (2001) Multiple sclerosis functional composite (MSFC): administration and scoring manual. National Multiple Sclerosis Society, New York"},{"key":"7707_CR10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/01.wnl.0000228242.53336.90","volume":"67","author":"R Schule","year":"2006","unstructured":"Schule R, Holland-Letz T, Klimpe S, Kassubek J, Klopstock T, Mall V, Otto S, Winner B, Sch\u00f6ls L (2006) The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology 67:430\u2013434","journal-title":"Neurology"},{"key":"7707_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.60.1.31","volume":"60","author":"JC Hobart","year":"2003","unstructured":"Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ (2003) Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 60:31\u201336","journal-title":"Neurology"},{"key":"7707_CR12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/jnnp.69.2.150","volume":"69","author":"C McDermott","year":"2000","unstructured":"McDermott C, White K, Bushby K, Shaw P (2000) Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry 69:150\u2013160","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7707_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrn2990","volume":"12","author":"C Blackstone","year":"2011","unstructured":"Blackstone C, O\u2019Kane CJ, Reid E (2011) Hereditary spastic paraplegias: membrane traffic and the motor pathway. Nat Rev Neurosci 12:31\u201342","journal-title":"Nat Rev Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7707-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7707-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7707-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:22:51Z","timestamp":1559071371000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7707-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,26]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["7707"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7707-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,26]]}}}